Evidence map›Paper›PMID 42194363›Full record

ArticleHealthcare (Basel, Switzerland)2026

The Perception and Development of Virtual Multidisciplinary Teams in Oncology in the Post-COVID-19 Era.

Ladina Greuter, Nicole Alexandra Frank, Markus W Gross, Heinz Läubli, Dominik Cordier

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ladina GreuterDepartment of Neurosurgery, University Hospital Basel, 4031 Basel, Switzerland.
Nicole Alexandra FrankDepartment of Neurosurgery, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0002-7109-3692
Markus W GrossDepartment of Radiation Oncology, University Hospital Basel, 4031 Basel, Switzerland.
Heinz LäubliDepartment of Oncology, University Hospital Basel, 4031 Basel, Switzerland.
Dominik CordierDepartment of Neurosurgery, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0002-3301-1908

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultidisciplinary team meetings (MDTs) are a mandatory requirement of modern oncology. During the COVID-19 pandemic, virtual MDTs replaced nearly all face-to-face MDTs. This study evaluated strengths, weaknesses, perceived quality, and outcomes of virtual MDTs compared to face-to-face MDTs. Furthermore, the extent of permanent implementation of virtual MDTs in oncology after COVID-19 was evaluated.

methodsSwitzerland-wide, participants of MDTs were surveyed with 44 questions concerning different dimensions of perceived meeting quality and technical aspects. Descriptive and comparative analysis was performed.

resultsIn 170 responses, communication discipline, meeting dedication, or perceived quality were rated comparably to standard MDTs. Time efficiency and outcomes of virtual meetings were rated similarly by 68% and 75% of all participants, respectively. Workspace setup did not significantly influence the subjective quality, while surgeons were less likely to rate the quality as good. After COVID-19, 41 (38%) of 108 MDTs have been permanently converted to a virtual format.

conclusionA substantial proportion of Swiss MDTs have permanently switched to a purely virtual format or offer a hybrid option. Meeting quality, communication discipline, and dedication were comparable. However, assessing the quality of MDTs remains challenging due to their multifactorial nature.

Indexed as

multidisciplinary oncologymultidisciplinary tumor boardvirtual conference

Identifiers

PMID42194363
PMCPMC13206058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.